Progrex Ventures (531265)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trading at ₹16.42, a ~23.5% discount to book value of ₹21.47 (P/B 0.76).
• Market capitalisation of ₹6 Cr is tiny, so the entire enterprise can be bought for less than stated book equity.
• Latest quarter shows near-zero net loss (₹-0 Cr), implying no immediate large cash burn eroding book value.
• No dividend obligation and no visible sales overhead, keeping the cost structure very low.

Concerns

• Zero sales in the latest quarter; there is no revenue stream or visible operating business.
• ROE -2.28% and ROCE -1.89% indicate ongoing value destruction.
• Piotroski F-Score of 2/9 signals extremely weak fundamental health.
• Current price ₹16.42 is below the stated 52-week range low ₹21.48, suggesting poor liquidity or unreliable pricing.

AI Analysis

At first glance, Progrex Ventures looks like a classic Graham net-net: selling at ₹16.42 against a book value of ₹21.47, a 24% discount. But let me stop right there. Value investing is not buying cheap things; it is buying good businesses at a fair price. This is not a good business. Sales in the latest quarter are exactly ₹0 crore. Net profit is ₹0 crore. ROE is -2.28% and ROCE is -1.89%. There is no earnings engine, no moat, and no growth to underwrite. The Piotroski F-Score of 2/9 only confirms the balance sheet and profitability signals are weak. A P/E of 0.00 is not a bargain; it is a warning that the 'E' is absent. With market cap at ₹6 crore, the whole company can be bought for less than its stated book equity, but book value is only as useful as the assets behind it. If assets are worth real rupees, there may be an asset play. However, negative returns on equity mean management is slowly destroying the stated value. I would not rely on the 52-week range of ₹21.48–₹29.58 because the current price sits below even the lower end, which raises liquidity and data-quality questions. This is not a stalwart or a grower; it is a candidate for a deep-value asset play—if, and only if, the book value is independently verified and the assets can be realised or deployed. Until I see sales, margins, or a credible plan, this remains a cigar butt with one puff left. For an Indian retail investor, capital preservation matters. Shareholder equity of ₹21.47 per share is a cushion, but negative earnings can shrink that cushion. Watch the quarterly losses and any asset sales. Price to book alone can trap you; price to value with a margin of safety, based on facts, is the only path. No dividend, no growth, no profits—so the burden of proof is entirely on management.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer